title: Evidence that the endogenous histone H1 phosphatase in HeLa mitotic chromosomes is protein phosphatase 1, not protein phosphatase 2A.
abstract: Histone H1 is highly phosphorylated in mitotic HeLa cells, but is quickly dephosphorylated in vivo at the end of mitosis and in vitro following cell lysis. We show here that okadaic acid and microcystin-LR block the in vitro dephosphorylation of H1 and that they do so directly by inhibiting the histone H1 phosphatase rather than by some indirect mechanism. The concentrations of microcystin and okadaic acid required for inhibition strongly suggest that the histone H1 phosphatase is either PP1 or an unknown protein phosphatase with okadaic acid-sensitivity similar to PP1. The histone H1 phosphatase is predominantly located in chromosomes with at most one copy for every 86 nucleosomes. This tends to support its identification as PP1, since localization in mitotic chromosomes is a characteristic of PP1 but not of the other known okadaic acid-sensitive protein phosphatases. We also show that treatment of metaphase-arrested HeLa cells with staurosporine and olomoucine, inhibitors of p34cdc2 and other protein kinases, rapidly induces reassembly of interphase nuclei and dephosphorylation of histone H1 without chromosome segregation. This result indicates that protein kinase activity must remain elevated to maintain a mitotic block. Using this as a model system for the M- to G1-phase transition, we present evidence from inhibitor studies suggesting that the in vivo histone H1 phosphatase may be either PP1 or another phosphatase with similar okadaic acid-sensitivity, but not PP2A.
authors.affiliation: Department of Chemistry, University of Wisconsin-Oshkosh 54901-8645, USA. paulson@vaxa.cis.uwosh.edu
authors.forename: J R
authors.initials: JR
authors.lastname: Paulson
authors.forename: J S
authors.initials: JS
authors.lastname: Patzlaff
authors.forename: A J
authors.initials: AJ
authors.lastname: Vallis
mesh_terms: D002467:Cell Nucleus / Q000187:drug effects; D002843:Chromatin / Q000201:enzymology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006367:HeLa Cells; D006657:Histones / Q000378:metabolism*; D006801:Humans; D007701:Kinetin; D008387:Marine Toxins; D008677:Metaphase; D052998:Microcystins; D008938:Mitosis; D019319:Okadaic Acid / Q000494:pharmacology; D010080:Oxazoles / Q000494:pharmacology; D010456:Peptides, Cyclic / Q000494:pharmacology; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D010766:Phosphorylation; D047428:Protein Kinase Inhibitors; D054645:Protein Phosphatase 1; D054648:Protein Phosphatase 2; D011687:Purines / Q000494:pharmacology; D019311:Staurosporine / Q000494:pharmacology
chemical_list: D002843:Chromatin; D004791:Enzyme Inhibitors; D006657:Histones; D008387:Marine Toxins; D052998:Microcystins; D010080:Oxazoles; D010456:Peptides, Cyclic; D047428:Protein Kinase Inhibitors; D011687:Purines; D019319:Okadaic Acid; C090046:olomoucine; C059041:calyculin A; D010749:Phosphoprotein Phosphatases; D054645:Protein Phosphatase 1; D054648:Protein Phosphatase 2; C057862:cyanoginosin LR; D019311:Staurosporine; D007701:Kinetin